Chill Brands Group PLC (GB:CHLL)
LSE:CHLL
Top Page
Chill Brands Group PLC
(LSE:CHLL)
Select Model
Select Model
Rating:42Neutral
Price Target:
0.48 p
▼(-38.59% Downside)
Action:ReiteratedDate:03/31/26
The score is primarily held down by weak financial performance (persistent losses, negative operating/free cash flow, and negative equity). Technicals add further pressure due to a sustained downtrend (below key moving averages and negative MACD), while valuation provides limited support because the company is loss-making (negative P/E) and no dividend yield is available.
Positive Factors
Niche nicotine product focus
A focused product portfolio centered on nicotine pouches and related lifestyle goods gives Chill Brands a clear business model and strategic clarity. Specialist product development and brand emphasis can enable deeper category expertise, faster product iteration, and clearer positioning versus generalist competitors over months.
Negative Factors
Negative shareholders' equity
The shift to negative shareholders' equity materially weakens the balance sheet, constraining financing options and raising solvency risk. Negative equity complicates lender and supplier confidence, may trigger covenant issues, and reduces the company's ability to absorb further losses without external capital.
Read all positive and negative factors
Positive Factors
Negative Factors
Niche nicotine product focus
A focused product portfolio centered on nicotine pouches and related lifestyle goods gives Chill Brands a clear business model and strategic clarity. Specialist product development and brand emphasis can enable deeper category expertise, faster product iteration, and clearer positioning versus generalist competitors over months.
Read all positive factors
Chill Brands Group PLC (CHLL) vs. iShares MSCI United Kingdom ETF (EWC)
Market Cap
£2.35M
Dividend YieldN/A
Average Volume (3M)1.28M
Price to Earnings (P/E)―
Beta (1Y)-0.35
Revenue GrowthN/A
EPS GrowthN/A
CountryUK
Employees7
SectorHealthcare
Sector Strength45
IndustryDrug Manufacturers - Specialty & Generic
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding522,926,800
10 Day Avg. Volume1,166,436
30 Day Avg. Volume1,284,919
Financial Highlights & Ratios
PEG Ratio0.23
Price to Book (P/B)-6.48
Price to Sales (P/S)21.60
P/FCF Ratio-3.40
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Chill Brands Group PLC Business Overview & Revenue Model
Company Description
Chill Brands Group PLC engages in the research, development, production, and sale of cannabidiol (CBD) consumer products and other lifestyle goods in the United States and the United Kingdom. The company offers tobacco alternative products, includ...
How the Company Makes Money
null...
Chill Brands Group PLC Financial Statement Overview
Summary
Income Statement
12
Very Negative
Balance Sheet
18
Very Negative
Cash Flow
10
Very Negative
| Breakdown | Sep 2025 | Mar 2025 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 370.50K | 305.70K | 1.91M | 624.19K | 320.88K |
| Gross Profit | -403.24K | -395.58K | 472.81K | -778.81K | -40.64K |
| EBITDA | -2.41M | -2.88M | -2.75M | -5.46M | -4.78M |
| Net Income | -2.88M | -3.30M | -3.37M | -5.71M | -4.85M |
Balance Sheet | |||||
| Total Assets | 2.14M | 2.13M | 5.27M | 3.26M | 1.76M |
| Cash, Cash Equivalents and Short-Term Investments | 99.96K | 30.95K | 1.32M | 420.05K | 333.18K |
| Total Debt | 2.66M | 1.74M | 1.81M | 337.02K | 80.42K |
| Total Liabilities | 3.37M | 2.86M | 2.69M | 1.72M | 1.99M |
| Stockholders Equity | -1.23M | -731.00K | 2.57M | 1.54M | -224.18K |
Cash Flow | |||||
| Free Cash Flow | -2.35M | -1.22M | -4.19M | -5.61M | -985.99K |
| Operating Cash Flow | -2.35M | -1.22M | -4.19M | -4.96M | -984.64K |
| Investing Cash Flow | -4.49K | -982.00 | 0.00 | -644.64K | 300.54K |
| Financing Cash Flow | 1.14M | -66.89K | 1.74M | 5.64M | 623.25K |
Chill Brands Group PLC Peers Comparison
UnderperformOutperform
Sector (51)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
67 Neutral | £33.25B | 20.15 | 6.43% | 1.51% | -2.12% | 42.10% | |
65 Neutral | £77.36M | -8.91 | -0.12% | ― | ― | ― | |
63 Neutral | £91.88M | -1.10 | 206.44% | ― | 93.48% | 51.18% | |
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% | |
45 Neutral | £652.25M | -9.44 | 227.10% | ― | -0.28% | 22.94% | |
45 Neutral | £22.87M | -11.67 | -51.21% | ― | 61.13% | 33.33% | |
42 Neutral | £2.35M | -2.77 | ― | ― | ― | ― |
* Healthcare Sector Average
GB:CHLL
Chill Brands Group PLC
0.45
-1.70
-79.07%
GB:AGY
Allergy Therapeutics
10.30
4.15
67.48%
GB:PXS
Provexis
0.98
0.48
95.00%
GB:STX
Shield Therapeutics
8.60
5.95
224.53%
GB:VLG
Venture Life
63.50
24.50
62.82%
GB:HLN
Haleon PLC
372.90
22.77
6.50%
Chill Brands Group PLC Corporate Events
Business Operations and StrategyExecutive/Board Changes
Chill Brands Director Steps Down as Board Reviews Committee Structure
Neutral
Mar 31, 2026
Chill Brands Group has announced the immediate resignation of Non-Executive Director Nick Tulloch, who is stepping down to concentrate on his other business interests. The board has thanked Tulloch for his contribution and said it will review the ...
Business Operations and StrategyFinancial Disclosures
Chill Brands accelerates revenue growth as Chill Connect outpaces UK convenience demand
Positive
Feb 9, 2026
Chill Brands reported strong momentum at its Chill Connect distribution platform, with product sales revenue growing more than 55% month-on-month on average between October 2025 and January 2026. Combined monthly revenues from product sales and se...
Business Operations and StrategyExecutive/Board ChangesFinancial Disclosures
Chill Brands Posts Extended 18-Month Results After Governance Turmoil and Strategic Reset
Negative
Jan 30, 2026
Chill Brands Group has released its audited final results for an extended 18‑month financial period to 30 September 2025, reflecting a highly unusual and transitional phase marked by governance disruption, operational challenges and a strate...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.